Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 11, 2003, Pages 827-832

  Li, Jinliang ^a   Li, Ping ^a   Feng, Xinheng ^a   Li, Zhaoping ^a   Hou, Rong ^a   Han, Chide ^a   Zhang, Youyi ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Cardiac hypertrophy; cDNA microarray; Gene expression; Losartan; Pressure overload

Indexed keywords

COMPLEMENTARY DNA; LOSARTAN;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; ATTENUATION; BLOOD PRESSURE REGULATION; BODY WEIGHT; CONTROLLED STUDY; DNA FINGERPRINTING; DNA MICROARRAY; DOSE RESPONSE; GENE EXPRESSION; GENE FUNCTION; GENE INDUCTION; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART VENTRICLE OVERLOAD; HEART WEIGHT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; STATISTICAL SIGNIFICANCE; UNINDEXED SEQUENCE;

ANIMALS; GENE EXPRESSION PROFILING; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR;

EID: 0345167081     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03917.x     Document Type: Article

References (23)

1. Loennechen JP, Wisloff U, Falck G, Ellingsen O. Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure. Circulation 2002; 105: 1380-6.
2. Wachtell K, Bella JN, Rokkedal J et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) study. Circulation 2002; 105: 1071-6.
3. Baba HA, Iwai T, Bauer M, Irlbeck M, Schmid KW, Zimmer HG. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats. J. Mol. Cell. Cardiol. 1999; 31: 445-55.
4. Kiatchoosakun S, Lawrence E, Nakada S, Restivo J, Walsh RA, Hoit BD. Effect of angiotensin type I-receptor blockade on left ventricular remodeling in pressure overload hypertrophy. J. Card. Fail. 2001; 7: 342-7.
5. Shiffman D, Porter JG. Gene expression profiling of cardiovascular disease models. Curr. Opin. Biotechnol. 2000; 11: 598-601.
6. Jin H, Yang R, Awad TA et al. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 2001; 103: 736-42.
7. Reddy DS, Singh M, Ghosh S, Ganguly NK. Role of cardiac renin-angiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction. Mol. Cell. Biochem. 1996; 155: 1-11.
8. Walker J, Rigley K. Gene expression profiling in human peripheral blood mononuclear cells using high-density filter-based cDNA microarrays. J. Immunol. Methods 2000; 239: 167-79.
9. McCormick SM, Eskin SG, McIntire LV et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc. Natl Acad. Sci. USA 2001; 98: 8955-60.
10. Campos AH, Zhao Y, Pollman MJ, Gibbons GH. DNA microarray profiling to identify angiotensin-responsive genes in vascular smooth muscle cells: Potential mediators of vascular disease. Circ. Res. 2003; 92: 111-18.
11. Jouannot P, Hart P. Rat myocardial mechanics during pressure-induced hypertrophy development and reversal. Am. J. Physiol. 1975; 229: 355-64.
12. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ. Res. 2000; 86: 580-8.
13. Barger PM, Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms. Am. J. Med. Sci. 1999; 318: 36-42.
14. De Windt LJ, Lim HW, Bueno OF et al. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc. Natl Acad. Sci. USA 2001; 98: 3322-7.
15. Shimamura T, Iwasaki T, Hayasaki-Kajiwara Y, Naya N, Nakajima M. Effects of losartan arid benazepril on abnormal circadian blood pressure rhythm and target organ damage in SHRSP. Clin. Exp. Hypertens. 2002; 24: 187-205.
16. Ling Q, Chen TH, Guo ZG. Inhibition of beta-myosin heavy chain gene expression in pressure overload rat heart by losartan and captopril. Acta Pharmacol. Sin. 1997; 18: 63-6.
17. Emdad L, Uzzaman M, Takagishi Y et al. Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: Prevention by angiotensin II type 1 receptor blockade. J. Mol. Cell. Cardiol. 2001; 33: 219-31.
18. Araki M, Kanda T, Imai S, Suzuki T, Murata K, Kobayashi I. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. J. Cardiovasc. Pharmacol. 1995; 26: 61-5.
19. Sakamoto K, Yamasaki Y, Kaneto H et al. Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization. FEBS Lett. 1999; 461: 47-51.
20. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family. A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 2002; 33: 337-49.
21. Paulus WJ. Natriuretic peptides to probe haemodynamic overload in hypertrophic cardiomyopathy. Eur. Heart J. 2001; 22: 1249-51.
22. Kester HA, Blanchetot C, den Hertog J, van der Saag PT, van der Burg B. Transforming growth factor-beta-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo-and heterodimerize and has transcriptional represser activity. J. Biol. Chem. 1999; 274: 27 439-47.
23. Menshikov M, Elizarova E, Plakida K et al. Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis. Biochem. J. 2002; 367: 833-9.